Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Burden

Showing results (41-50 of 189) with videos related to

Pageof 19
Sort By:
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 2, 2011
The impact of pharmacist interventions on osteoporosis management: a systematic reviewM N Elias, A M Burden, S M Cadarette
Paediatric Drugs|December 14, 2024
How Consistent are Anti-Infective Drug Dosing Recommendations Across Three European Paediatric Formularies?Lukas Higi, Elisabeth Carydias, Andrea M Burden, et al.
Drug Safety|June 14, 2020
Thromboembolic Safety Reporting of Tofacitinib and Baricitinib: An Analysis of the WHO VigiBaseEnriqueta Vallejo-Yagüe, Stefan Weiler, Raphael Micheroli, et al.
Clinical and Translational Science|May 1, 2025
Integrating Sustainability Pillars Into Trial Design Decision-Making: Results of an International SurveyPritibha Singh, Oleksandr Sverdlov, Robert A Beckman, et al.
Clinical Pharmacology and Therapeutics|July 25, 2023
Design and Execution of Sustainable Decentralized Clinical TrialsPritibha Singh, Andrea M Burden, Fanni Natanegara, et al.
Archives of Osteoporosis|March 12, 2013
Variation in the days supply field for osteoporosis medications in OntarioAndrea M Burden, Anjie Huang, Mina Tadrous, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 22, 2015
Uptake and characteristics of zoledronic acid and denosumab patients and physicians in Ontario, Canada: impact of drug formulary accessA M Burden, M Tadrous, A Calzavara, et al.
Swiss Medical Weekly|August 14, 2025
Opioid-containing antitussives in Switzerland: a descriptive cross-sectional time-series analysis of pharmacy sales 2013-2022Lucia Gasparovic, Dominik Stämpfli, Shanzeh Chaudhry, et al.
Plos Computational Biology|June 2, 2023
Patient groups in Rheumatoid arthritis identified by deep learning respond differently to biologic or targeted synthetic DMARDsMaria Kalweit, Andrea M Burden, Joschka Boedecker, et al.
Research in Social & Administrative Pharmacy : RSAP|July 10, 2021
Assessment of minor health disorders with decision tree-based triage in community pharmaciesDominik Stämpfli, Birgit A Winkler, Simona Berardi Vilei, et al.
Pageof 19

Showing results (41-50 of 189) with videos related to

Sort By:
Pageof 19
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 2, 2011
The impact of pharmacist interventions on osteoporosis management: a systematic reviewM N Elias, A M Burden, S M Cadarette
Paediatric Drugs|December 14, 2024
How Consistent are Anti-Infective Drug Dosing Recommendations Across Three European Paediatric Formularies?Lukas Higi, Elisabeth Carydias, Andrea M Burden, et al.
Drug Safety|June 14, 2020
Thromboembolic Safety Reporting of Tofacitinib and Baricitinib: An Analysis of the WHO VigiBaseEnriqueta Vallejo-Yagüe, Stefan Weiler, Raphael Micheroli, et al.
Clinical and Translational Science|May 1, 2025
Integrating Sustainability Pillars Into Trial Design Decision-Making: Results of an International SurveyPritibha Singh, Oleksandr Sverdlov, Robert A Beckman, et al.
Clinical Pharmacology and Therapeutics|July 25, 2023
Design and Execution of Sustainable Decentralized Clinical TrialsPritibha Singh, Andrea M Burden, Fanni Natanegara, et al.
Archives of Osteoporosis|March 12, 2013
Variation in the days supply field for osteoporosis medications in OntarioAndrea M Burden, Anjie Huang, Mina Tadrous, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 22, 2015
Uptake and characteristics of zoledronic acid and denosumab patients and physicians in Ontario, Canada: impact of drug formulary accessA M Burden, M Tadrous, A Calzavara, et al.
Swiss Medical Weekly|August 14, 2025
Opioid-containing antitussives in Switzerland: a descriptive cross-sectional time-series analysis of pharmacy sales 2013-2022Lucia Gasparovic, Dominik Stämpfli, Shanzeh Chaudhry, et al.
Plos Computational Biology|June 2, 2023
Patient groups in Rheumatoid arthritis identified by deep learning respond differently to biologic or targeted synthetic DMARDsMaria Kalweit, Andrea M Burden, Joschka Boedecker, et al.
Research in Social & Administrative Pharmacy : RSAP|July 10, 2021
Assessment of minor health disorders with decision tree-based triage in community pharmaciesDominik Stämpfli, Birgit A Winkler, Simona Berardi Vilei, et al.
Pageof 19